Breast
biopsy market insights and analysis by product, technique type, guidance technology, end
users- forecast till 2027. It is predicted that the popularity of minimally
invasive biopsy techniques would increase the market share for breast biopsies.
Market Research Future creates industry reports for the medical device sector
that emphasize market expansion prospects. Through the projection period, an
advantageous CAGR will permit efficient market growth.
It is
anticipated that more women will choose to get preventive exams for the
condition, leading to an increase in breast cancer screening cases. Thus, it is
projected that the market for biopsy equipment will expand in tandem with the
number of biopsies conducted. Demand for breast biopsies is anticipated to rise
in the near future due to the effectiveness of ultrasound-guided breast
biopsies.
Competitive Analysis
The
diversification of risk and assets owned is estimated to be seen as a major
trend in the impending period. Investors' role in the revitalization of the
market's operation and growth is anticipated to be vital. The increased
reliance on e-commerce platforms to push the sales level is estimated to be
another key factor that will drive the development of the global market in the
approaching period. The leveraging of AI and IoT is estimated to gain traction
with more integration of technology in the operations related to production and
logistics in the upcoming period.
It is
anticipated that the development of an unique workplace would have even more of
an impact on the worldwide market. With the execution of new tactics, the
market is poised to change the direction of development in the near future. The
restoration of consumer demand and financial viability are considered to offer
positive odds for the expansion of the firms during the projection period.
The
important companies in the breast biopsy market are Argon Medical Devices,
Inc., NuVue Therapeutics, Devicor Medical Products Inc. Hologic Inc. Argon
Medical Devices, Cook Medical Incorporated, Leica Biosystems, Encapsule Medical
Devices LLC., Johnson & Johnson, Becton, Dickinson and Company, Galini SRL,
C.R. Bard Inc., Intact Medical Corporation, Conceptus INC, Hologic Inc., Karl
Storz GmbH & Co. Kg and GE Healthcare.
Segmental Analysis
The breast biopsy market players is segmental scrutiny has been
conducted based on technique type, product, guidance technology, region, and
end-user.
Based on
the end-user, the
breast biopsy market is segmented into ambulatory surgical centers, hospitals
diagnostic centers, and others.
Based on
the product, the
breast biopsy market has been segmented into biopsy tables, biopsy wires, biopsy needles, guidance systems, and others.
Based on
the region, the
breast biopsy market is segmented into Europe, the Middle East, the Americas,
Asia Pacific, and Africa.
Based on
the technique type,
the breast biopsy market is segmented into core needle biopsy, wire
localization, biopsy markers, MRI-guided core needle biopsy, fine-needle
aspiration biopsy, surgical biopsy, and sentinel node biopsy.
Based on
the guidance technology, the breast biopsy market is segmented into mammography-guided magnetic
resonance, ultrasound-guided, CT-guided biopsy, and other image-guided breast
biopsies such as PET and thermography.
Detailed Regional Analysis
The regions
under examination for the breast biopsy market include Europe, the Middle East,
the Americas, Asia Pacific, and Africa. The North American region is expected
to hold the biggest market share in the breast biopsy market due to the
region's widespread use of cutting-edge medical technology and the industry's
ongoing expansion. The areas of North America and Europe, which are thought to
account for more than half of the breast biopsy market share, are the primary
drivers of the global market.
The
European breast biopsy market is anticipated to hold the subsequent principal
breast biopsy market share as breast cancer is most widespread in the UK and
Belgium. The breast biopsy market portion in the Asia Pacific region is also
anticipated to undergo evolution in the near future due to admission to optimal
treatment facilities, mounting demand for progressive technology, improved
adoption rate, collective government advantages, and intensifying healthcare
spending. The breast biopsy market in the Middle East and Africa is anticipated
to control the global market's smallest cut due to a small healthcare segment,
absence of technical knowledge, and modest medical facilities.
About Market Research Future:
Market Research Future (MRFR) is a
global market research company that takes pride in its services, offering a
complete and accurate analysis with regard to diverse markets and consumers
worldwide. Market Research Future has the distinguished objective of providing
the optimal quality research and granular research to clients. Our market
research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help answer your
most important questions.
Contact Us:
Market Research
Future (Part of Wantstats Research and Media Private Limited)
99 Hudson
Street, 5Th Floor
New York,
NY 10013
United
States of America
+1 628 258
0071 (US)
+44 2035
002 764 (UK)
Email:
sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
No comments:
Post a Comment